Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
Sponsors
University of Alberta, Memorial Hermann Health System, Second Affiliated Hospital, School of Medicine, Zhejiang University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Xuanwu Hospital, Beijing
Conditions
Acute Ischemic StrokeBrain IschemiaCerebral InfarctionLarge Vessel OcclusionStrokeStroke IschemicTenecteplaseTransportation of Patients
Phase 1
Phase 2
Phase 3
Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial
Not yet recruitingNCT07073469
Start: 2025-09-01End: 2027-11-01Target: 330Updated: 2025-08-15
Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users
RecruitingNCT07092709
Start: 2025-08-14End: 2028-12-31Target: 912Updated: 2025-12-16
Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours
RecruitingNCT07253181
Start: 2026-01-06End: 2028-03-30Target: 572Updated: 2026-08-19
Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging
Not yet recruitingNCT07475949
Start: 2026-09-01End: 2028-12-01Target: 352Updated: 2026-08-31